Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.
Upperton continues growth with appointment of Michael Mellor-Clark as Chief Commercial Officer.
FooterNews
Upperton Pharma Solutions Named Champion Award Winner in 2025 CDMO Leadership Awards
Upperton is proud to announce its recognition as the Champion Award Winner in the Small Molecule Dosage Form category at the CDMO Leadership Awards.
Upperton Announced as ‘Excellence in Innovation’ Finalist in Medilink Midlands Business Awards 2025
We are delighted to share that we have been shortlisted as a finalist in the Excellence in Innovation category at the Medilink Midlands Business Awards 2025.
Upperton Pharma Solutions Named Winner in 2025 CDMO Leadership Awards
Upperton is proud to announce its selection as a winner in the Small Molecule Dosage Form category at the CDMO Leadership Awards.
Upperton Completes Build of New £7m Sterile Manufacturing Facility
Upperton completes build of new £7m Nottingham sterile manufacturing facility for parenteral, nasal and pulmonary delivery.
Upperton continues growth with appointment of Lorna Patrick as Chief Operating Officer
Upperton continues growth with appointment of Lorna Patrick as Chief Operating Officer
Upperton honoured at Sunday Times 100 Fastest Growing Companies Ceremony
Upperton honoured at Sunday Times 100 Fastest Growing Companies ceremony.
Upperton wins Pharma Project of the Year at the Pharma Industry Awards UK 2024
Upperton wins Pharma Project of the Year at the Pharma Industry Awards UK 2024.
Upperton Pharma Solutions Adds Large-Scale Processing following MHRA Approval at Nottingham Facility
Upperton Pharma Solutions Adds Large-Scale Processing following MHRA Approval at Nottingham Facility, Trent Gateway.
Upperton wins Outstanding Achievement at Medilink UK National Healthcare Business Awards 2024
Upperton win’s Outstanding Achievement at Medilink UK National Healthcare Business Awards 2024 for Trent Gateway facility build.
